Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Recruiting now

Conditions studied: Gastric Cancer, Intestinal Metaplasia, Atrophic Gastritis

In brief

The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG

Key facts

Study ID

NCT04840056

Run by

Chinese University of Hong Kong

People needed

1300

Starts

2021-04-15

Expected to finish

2025-12-31

Last updated by the study team

2024-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults >= 18 years of age
• Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)

You may not qualify if…

• none

Where it is running

• Prince of Wales Hospital — Shatin, New Territories, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.